===== phenotype 10=================================================================
proportion of pts: 0.168980563269
lambda: 12631.9373259
----------------------------------------
Disorders of lipoid metabolism	0.141
Hypertensive disease	0.138
Range name na	0.127
Symptoms involving respiratory system and other chest symptoms	0.115
Diabetes	0.098
Arthropathies and related disorders	0.097
Ischemic heart disease	0.095
Other forms of heart disease	0.095
General symptoms	0.094
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.133
Cardiotonic Agents	0.122
Anti-Inflammatory Agents, Non-Steroidal	0.100
Antihypertensive Agents	0.099
Cyclooxygenase Inhibitors	0.095
Antipyretics	0.095
Fibrinolytic Agents	0.091
Platelet Aggregation Inhibitors	0.091
Hypolipidemic Agents	0.087
Vitamins	0.087
===== phenotype 45=================================================================
proportion of pts: 0.167393891313
lambda: 11851.4355168
----------------------------------------
Disorders of the eye and adnexa	0.183
Hypertensive disease	0.146
Diabetes	0.143
Disorders of lipoid metabolism	0.132
Arthropathies and related disorders	0.110
Rheumatism, excluding the back	0.107
Organic sleep disorders	0.091
Range name na	0.088
----------------------------------------
Anticholesteremic Agents	0.110
Antihypertensive Agents	0.109
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.105
Antipyretics	0.104
Anti-Inflammatory Agents, Non-Steroidal	0.102
Cyclooxygenase Inhibitors	0.102
Platelet Aggregation Inhibitors	0.099
Fibrinolytic Agents	0.097
Hypoglycemic Agents	0.090
Diuretics	0.083
===== phenotype 2=================================================================
proportion of pts: 0.186037286791
lambda: 11355.4049109
----------------------------------------
Disorders of lipoid metabolism	0.173
Hypertensive disease	0.162
Other diseases of the upper respiratory tract	0.148
Acute respiratory infections	0.129
Diseases of esophagus, stomach, and duodenum	0.120
Range name na	0.091
Rheumatism, excluding the back	0.090
Diseases of the ear and mastoid process	0.088
----------------------------------------
Anti-Allergic Agents	0.134
Bronchodilator Agents	0.123
Anti-Inflammatory Agents	0.120
Dermatologic Agents	0.119
Histamine H1 Antagonists, Non-Sedating	0.114
Anti-Ulcer Agents	0.110
Proton Pump Inhibitors	0.103
Antihypertensive Agents	0.090
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.086
===== phenotype 14=================================================================
proportion of pts: 0.163823879413
lambda: 10993.8890083
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.140
Hypertensive disease	0.140
Disorders of lipoid metabolism	0.130
General symptoms	0.117
Diabetes	0.104
Chronic obstructive pulmonary disease and allied conditions	0.103
Range name na	0.101
Disorders of the eye and adnexa	0.083
Disorders of thyroid gland	0.081
----------------------------------------
Tocolytic Agents	0.105
Anticholesteremic Agents	0.101
Hypolipidemic Agents	0.094
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.094
Adrenergic beta-2 Receptor Agonists	0.091
Bronchodilator Agents	0.091
Serotonin Uptake Inhibitors	0.087
Anticonvulsants	0.086
Anti-Anxiety Agents	0.085
GABA Modulators	0.085
Hypnotics and Sedatives	0.082
===== phenotype 12=================================================================
proportion of pts: 0.168980563269
lambda: 10586.7029904
----------------------------------------
Other forms of heart disease	0.195
Range name na	0.136
Hypertensive disease	0.120
Nephritis, nephrotic syndrome, and nephrosis	0.120
General symptoms	0.115
Symptoms involving urinary system	0.108
Symptoms involving respiratory system and other chest symptoms	0.107
Other diseases of urinary system	0.099
----------------------------------------
Anti-Arrhythmia Agents	0.112
Sympatholytics	0.111
Vasodilator Agents	0.104
Antihypertensive Agents	0.101
Antipyretics	0.101
Anti-Inflammatory Agents, Non-Steroidal	0.100
Adrenergic beta-1 Receptor Antagonists	0.099
Fibrinolytic Agents	0.093
Platelet Aggregation Inhibitors	0.090
Cyclooxygenase Inhibitors	0.088
===== phenotype 47=================================================================
proportion of pts: 0.173740579135
lambda: 10557.2700153
----------------------------------------
Disorders of lipoid metabolism	0.238
Hypertensive disease	0.216
Ischemic heart disease	0.212
Diabetes	0.194
Symptoms involving respiratory system and other chest symptoms	0.140
----------------------------------------
Anti-Arrhythmia Agents	0.101
Sympatholytics	0.097
Vasodilator Agents	0.094
Adrenergic beta-1 Receptor Antagonists	0.093
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.091
Anti-Inflammatory Agents, Non-Steroidal	0.090
Fibrinolytic Agents	0.088
Cyclooxygenase Inhibitors	0.087
Platelet Aggregation Inhibitors	0.087
Antipyretics	0.086
Antihypertensive Agents	0.086
===== phenotype 29=================================================================
proportion of pts: 0.177310591035
lambda: 10407.2631149
----------------------------------------
Hypertensive disease	0.146
Disorders of lipoid metabolism	0.141
Range name na	0.126
Other forms of heart disease	0.120
Ischemic heart disease	0.107
Dorsopathies	0.096
Arthropathies and related disorders	0.093
Organic sleep disorders	0.089
General symptoms	0.082
----------------------------------------
Proton Pump Inhibitors	0.126
Anti-Ulcer Agents	0.126
Hypolipidemic Agents	0.116
Anticholesteremic Agents	0.115
Diuretics	0.115
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.115
Anti-Arrhythmia Agents	0.105
Sodium Chloride Symporter Inhibitors	0.101
Voltage-Gated Sodium Channel Blockers	0.081
===== phenotype 9=================================================================
proportion of pts: 0.15787385958
lambda: 10372.0793825
----------------------------------------
Arthropathies and related disorders	0.139
Hypertensive disease	0.123
Disorders of lipoid metabolism	0.120
Rheumatism, excluding the back	0.117
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.111
Nutritional deficiencies	0.106
Dorsopathies	0.103
Other diseases of skin and subcutaneous tissue	0.099
Range name na	0.082
----------------------------------------
Anticholesteremic Agents	0.120
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.120
Antipyretics	0.118
Platelet Aggregation Inhibitors	0.114
Anti-Inflammatory Agents, Non-Steroidal	0.111
Cyclooxygenase Inhibitors	0.110
Hypolipidemic Agents	0.105
Fibrinolytic Agents	0.104
Bone Density Conservation Agents	0.098
===== phenotype 27=================================================================
proportion of pts: 0.189607298691
lambda: 10172.6481096
----------------------------------------
Hypertensive disease	0.185
Diabetes	0.171
Disorders of lipoid metabolism	0.148
Range name na	0.115
General symptoms	0.104
Symptoms involving respiratory system and other chest symptoms	0.099
Rheumatism, excluding the back	0.097
Arthropathies and related disorders	0.080
----------------------------------------
Hypoglycemic Agents	0.143
Analgesics, Non-Narcotic	0.127
Angiotensin II Type 1 Receptor Blockers	0.123
Tubulin Modulators	0.110
Hypolipidemic Agents	0.102
Vitamins	0.102
Sodium Chloride Symporter Inhibitors	0.102
Diuretics	0.098
Antineoplastic Agents, Phytogenic	0.092
===== phenotype 25=================================================================
proportion of pts: 0.177310591035
lambda: 10011.2015053
----------------------------------------
Hypertensive disease	0.174
Range name na	0.133
Disorders of lipoid metabolism	0.130
Arthropathies and related disorders	0.123
Rheumatism, excluding the back	0.112
Other diseases of skin and subcutaneous tissue	0.110
Disorders of the eye and adnexa	0.109
Dorsopathies	0.108
----------------------------------------
Cardiotonic Agents	0.133
Angiotensin-Converting Enzyme Inhibitors	0.133
Anti-Inflammatory Agents	0.130
Glucocorticoids	0.125
Vitamins	0.113
Bone Density Conservation Agents	0.094
Anti-Allergic Agents	0.093
Antifungal Agents	0.090
Anti-Bacterial Agents	0.088
===== phenotype 33=================================================================
proportion of pts: 0.115827052757
lambda: 9991.93604143
----------------------------------------
Miscellaneous diagnostic and therapeutic procedures	0.126
Other diseases of respiratory system	0.112
Other forms of heart disease	0.111
Ischemic heart disease	0.109
Symptoms involving respiratory system and other chest symptoms	0.100
Operations on the cardiovascular system	0.092
Operations on the musculoskeletal system	0.090
Diseases of arteries, arterioles, and capillaries	0.089
Diseases of veins and lymphatics, and other diseases of circulatory system	0.086
Symptoms involving cardiovascular system	0.085
----------------------------------------
Anti-Inflammatory Agents, Non-Steroidal	0.109
Antipyretics	0.106
Analgesics, Non-Narcotic	0.106
Antihypertensive Agents	0.103
Platelet Aggregation Inhibitors	0.103
Fibrinolytic Agents	0.103
Cyclooxygenase Inhibitors	0.102
Anti-Arrhythmia Agents	0.096
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.088
Vasodilator Agents	0.083
===== phenotype 48=================================================================
proportion of pts: 0.163427211424
lambda: 9797.7627157
----------------------------------------
Hypertensive disease	0.161
General symptoms	0.146
Range name na	0.135
Disorders of thyroid gland	0.127
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.119
Rheumatism, excluding the back	0.114
Disorders of lipoid metabolism	0.106
Symptoms involving skin and other integumentary tissue	0.091
----------------------------------------
Vitamins	0.131
Bone Density Conservation Agents	0.115
Antioxidants	0.104
Antipyretics	0.100
Fibrinolytic Agents	0.097
Platelet Aggregation Inhibitors	0.095
Angiotensin-Converting Enzyme Inhibitors	0.092
Anti-Inflammatory Agents, Non-Steroidal	0.091
Antihypertensive Agents	0.089
Cyclooxygenase Inhibitors	0.087
===== phenotype 11=================================================================
proportion of pts: 0.179690598969
lambda: 9463.64759487
----------------------------------------
Hypertensive disease	0.153
Symptoms involving respiratory system and other chest symptoms	0.147
Range name na	0.145
General symptoms	0.137
Arthropathies and related disorders	0.120
Acute respiratory infections	0.107
Disorders of the eye and adnexa	0.096
Other forms of heart disease	0.095
----------------------------------------
Anti-Inflammatory Agents	0.140
Anti-Allergic Agents	0.133
Glucocorticoids	0.129
Histamine H1 Antagonists, Non-Sedating	0.106
Anti-Bacterial Agents	0.105
Antineoplastic Agents, Hormonal	0.101
Antiemetics	0.100
Bronchodilator Agents	0.100
Topoisomerase II Inhibitors	0.085
===== phenotype 19=================================================================
proportion of pts: 0.165410551369
lambda: 9235.15885621
----------------------------------------
Rheumatism, excluding the back	0.136
Arthropathies and related disorders	0.126
Hypertensive disease	0.118
Disorders of thyroid gland	0.116
Dorsopathies	0.114
Range name na	0.106
Disorders of lipoid metabolism	0.099
Other disorders of female genital tract	0.097
General symptoms	0.088
----------------------------------------
Anti-Allergic Agents	0.123
Calcium Channel Blockers	0.121
Anti-Inflammatory Agents	0.119
Anti-Arrhythmia Agents	0.116
Antihypertensive Agents	0.115
Vasodilator Agents	0.109
Anti-Inflammatory Agents, Non-Steroidal	0.105
Cyclooxygenase Inhibitors	0.100
Surface-Active Agents	0.092
===== phenotype 46=================================================================
proportion of pts: 0.170170567235
lambda: 9180.13531798
----------------------------------------
Acute respiratory infections	0.152
Symptoms involving respiratory system and other chest symptoms	0.140
Hypertensive disease	0.118
Other symptoms involving abdomen and pelvis	0.107
Other diseases of the upper respiratory tract	0.102
Infections of skin and subcutaneous tissue	0.101
Dorsopathies	0.095
Disorders of lipoid metabolism	0.093
Range name na	0.092
----------------------------------------
Antipyretics	0.128
Anti-Inflammatory Agents, Non-Steroidal	0.123
Cyclooxygenase Inhibitors	0.118
Antihypertensive Agents	0.111
Analgesics, Non-Narcotic	0.110
Anti-Arrhythmia Agents	0.108
Platelet Aggregation Inhibitors	0.106
Fibrinolytic Agents	0.103
Anti-Bacterial Agents	0.094
===== phenotype 8=================================================================
proportion of pts: 0.155493851646
lambda: 9147.19865093
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.129
General symptoms	0.121
Range name na	0.121
Hypertensive disease	0.113
Disorders of the eye and adnexa	0.112
Other inflammatory conditions of skin and subcutaneous tissue	0.106
Diseases of esophagus, stomach, and duodenum	0.102
Other diseases of urinary system	0.099
Symptoms involving skin and other integumentary tissue	0.096
----------------------------------------
Anti-Ulcer Agents	0.113
Sympatholytics	0.113
Proton Pump Inhibitors	0.112
Anti-Arrhythmia Agents	0.108
Adrenergic beta-1 Receptor Antagonists	0.101
Antihypertensive Agents	0.097
Anti-Inflammatory Agents	0.090
Analgesics	0.090
Anti-Allergic Agents	0.089
Anti-Anxiety Agents	0.087
===== phenotype 38=================================================================
proportion of pts: 0.13962713209
lambda: 9006.03012857
----------------------------------------
Hypertensive disease	0.135
Arthropathies and related disorders	0.127
Rheumatism, excluding the back	0.119
General symptoms	0.117
Disorders of lipoid metabolism	0.112
Disorders of the peripheral nervous system	0.110
Symptoms involving respiratory system and other chest symptoms	0.101
Symptoms involving urinary system	0.092
Other diseases of urinary system	0.088
----------------------------------------
Excitatory Amino Acid Antagonists	0.125
Antiparkinson Agents	0.123
Anticonvulsants	0.121
Antimanic Agents	0.113
Calcium Channel Blockers	0.112
Analgesics	0.112
Analgesics, Non-Narcotic	0.103
Anticholesteremic Agents	0.098
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.094
===== phenotype 6=================================================================
proportion of pts: 0.146370487902
lambda: 9004.50036175
----------------------------------------
Arthropathies and related disorders	0.137
Anemias	0.134
Disorders of the eye and adnexa	0.128
Diseases of esophagus, stomach, and duodenum	0.117
Disorders of lipoid metabolism	0.116
Hypertensive disease	0.109
Other diseases of intestines and peritoneum	0.095
Disorders of thyroid gland	0.085
Other symptoms involving abdomen and pelvis	0.080
----------------------------------------
Proton Pump Inhibitors	0.112
Anti-Ulcer Agents	0.109
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.107
Anticholesteremic Agents	0.107
Platelet Aggregation Inhibitors	0.100
Antipyretics	0.098
Fibrinolytic Agents	0.096
Anti-Inflammatory Agents, Non-Steroidal	0.094
Cyclooxygenase Inhibitors	0.089
Anti-Arrhythmia Agents	0.088
===== phenotype 44=================================================================
proportion of pts: 0.151527171757
lambda: 8868.74611007
----------------------------------------
Range name na	0.144
Hypertensive disease	0.134
Symptoms involving respiratory system and other chest symptoms	0.121
Other forms of heart disease	0.120
Rheumatism, excluding the back	0.101
Disorders of lipoid metabolism	0.099
Other diseases of respiratory system	0.098
Diabetes	0.093
Anemias	0.091
----------------------------------------
Antiemetics	0.130
Hypnotics and Sedatives	0.124
Anesthetics, Local	0.121
Analgesics, Opioid	0.119
Narcotics	0.113
Anti-Anxiety Agents	0.112
Anti-Ulcer Agents	0.099
Antipruritics	0.091
Histamine H2 Antagonists	0.090
===== phenotype 13=================================================================
proportion of pts: 0.128520428401
lambda: 8866.24534447
----------------------------------------
Hypertensive disease	0.209
Disorders of lipoid metabolism	0.175
Range name na	0.141
Arthropathies and related disorders	0.137
General symptoms	0.124
Symptoms involving respiratory system and other chest symptoms	0.110
Rheumatism, excluding the back	0.104
----------------------------------------
Immunosuppressive Agents	0.128
Antirheumatic Agents	0.128
Nucleic Acid Synthesis Inhibitors	0.127
Folic Acid Antagonists	0.127
Antimetabolites, Antineoplastic	0.127
Abortifacient Agents, Nonsteroidal	0.126
Enzyme Inhibitors	0.119
Dermatologic Agents	0.118
===== phenotype 41=================================================================
proportion of pts: 0.157477191591
lambda: 8791.2285645
----------------------------------------
Hypertensive disease	0.135
Symptoms involving respiratory system and other chest symptoms	0.131
Organic sleep disorders	0.125
Chronic obstructive pulmonary disease and allied conditions	0.123
Overweight, obesity and other hyperalimentation	0.113
Other diseases of the upper respiratory tract	0.111
Diabetes	0.095
Na	0.086
Symptoms involving cardiovascular system	0.082
----------------------------------------
Anti-Allergic Agents	0.122
Anti-Inflammatory Agents	0.110
Bronchodilator Agents	0.103
Dermatologic Agents	0.103
Vasodilator Agents	0.099
Calcium Channel Blockers	0.098
Diuretics	0.097
Antihypertensive Agents	0.096
Histamine H1 Antagonists, Non-Sedating	0.090
Anti-Bacterial Agents	0.082
===== phenotype 18=================================================================
proportion of pts: 0.174137247124
lambda: 8537.32527652
----------------------------------------
Arthropathies and related disorders	0.157
Hypertensive disease	0.150
Range name na	0.144
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.124
Dorsopathies	0.123
Rheumatism, excluding the back	0.123
Diseases of esophagus, stomach, and duodenum	0.094
Gout	0.087
----------------------------------------
Antihypertensive Agents	0.131
Analgesics, Non-Narcotic	0.129
Calcium Channel Blockers	0.124
Vasodilator Agents	0.118
Diuretics	0.109
Enzyme Inhibitors	0.107
Gout Suppressants	0.104
Anticonvulsants	0.099
Anti-Anxiety Agents	0.080
===== phenotype 15=================================================================
proportion of pts: 0.148353827846
lambda: 8485.23606709
----------------------------------------
Other diseases of urinary system	0.173
Symptoms involving urinary system	0.136
Other symptoms involving abdomen and pelvis	0.136
Other diseases of intestines and peritoneum	0.121
Symptoms involving digestive system	0.120
Dorsopathies	0.114
Hypertensive disease	0.106
Range name na	0.094
----------------------------------------
Antihypertensive Agents	0.118
Antipyretics	0.108
Anti-Inflammatory Agents, Non-Steroidal	0.106
Cyclooxygenase Inhibitors	0.101
Anti-Ulcer Agents	0.100
Platelet Aggregation Inhibitors	0.099
Fibrinolytic Agents	0.096
Anti-Allergic Agents	0.091
Vasodilator Agents	0.090
Diuretics	0.090
===== phenotype 26=================================================================
proportion of pts: 0.149147163824
lambda: 8437.1493243
----------------------------------------
General symptoms	0.150
Na	0.131
Rheumatism, excluding the back	0.124
Nonspecific findings on examination of blood	0.106
Symptoms involving head and neck	0.105
Hypertensive disease	0.103
Diseases of the ear and mastoid process	0.099
Symptoms involving skin and other integumentary tissue	0.095
Certain traumatic complications and unspecified injuries	0.087
----------------------------------------
Anti-Inflammatory Agents, Non-Steroidal	0.114
Cyclooxygenase Inhibitors	0.108
Antipyretics	0.107
Serotonin Uptake Inhibitors	0.106
Antihypertensive Agents	0.105
Antidepressive Agents, Second-Generation	0.099
Fibrinolytic Agents	0.096
Platelet Aggregation Inhibitors	0.091
Anti-Allergic Agents	0.090
Anti-Inflammatory Agents	0.084
===== phenotype 34=================================================================
proportion of pts: 0.155493851646
lambda: 8385.95557738
----------------------------------------
Hypertensive disease	0.129
Disorders of lipoid metabolism	0.121
Symptoms involving respiratory system and other chest symptoms	0.116
Range name na	0.100
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.096
Arthropathies and related disorders	0.094
Na	0.089
Neurotic, personality, nonpsychotic disorders	0.088
Diseases of esophagus, stomach, and duodenum	0.087
Symptoms involving urinary system	0.081
----------------------------------------
Anti-Ulcer Agents	0.143
Antidepressive Agents, Second-Generation	0.143
Serotonin Uptake Inhibitors	0.142
Proton Pump Inhibitors	0.141
Calcium Channel Blockers	0.115
Hypnotics and Sedatives	0.114
Vasodilator Agents	0.108
GABA-A Receptor Agonists	0.094
===== phenotype 16=================================================================
proportion of pts: 0.163823879413
lambda: 8297.79410527
----------------------------------------
Hypertensive disease	0.135
Arthropathies and related disorders	0.128
Anemias	0.125
Disorders of lipoid metabolism	0.110
Organic sleep disorders	0.107
Dorsopathies	0.106
Acute respiratory infections	0.105
Disorders of the eye and adnexa	0.097
Other symptoms involving abdomen and pelvis	0.087
----------------------------------------
Calcium Channel Blockers	0.140
Vasodilator Agents	0.122
Anticonvulsants	0.116
Hypnotics and Sedatives	0.111
Antihypertensive Agents	0.110
Analgesics	0.109
Anti-Inflammatory Agents, Non-Steroidal	0.101
Anti-Anxiety Agents	0.098
Cyclooxygenase Inhibitors	0.093
===== phenotype 17=================================================================
proportion of pts: 0.149940499802
lambda: 8278.467961
----------------------------------------
Disorders of lipoid metabolism	0.164
Nonspecific findings on examination of blood	0.154
Hypertensive disease	0.146
Cerebrovascular disease	0.119
Range name na	0.113
Diseases of arteries, arterioles, and capillaries	0.106
Ischemic heart disease	0.104
Diabetes	0.094
----------------------------------------
Anticholesteremic Agents	0.117
Fibrinolytic Agents	0.116
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.115
Antihypertensive Agents	0.113
Platelet Aggregation Inhibitors	0.113
Antipyretics	0.112
Anti-Inflammatory Agents, Non-Steroidal	0.112
Cyclooxygenase Inhibitors	0.110
Enzyme Inhibitors	0.091
===== phenotype 36=================================================================
proportion of pts: 0.142403808013
lambda: 8083.76774753
----------------------------------------
Range name na	0.154
Hypertensive disease	0.148
Disorders of lipoid metabolism	0.137
Other forms of heart disease	0.132
Arthropathies and related disorders	0.115
Rheumatism, excluding the back	0.109
Anemias	0.105
Disorders of the eye and adnexa	0.099
----------------------------------------
Sympatholytics	0.135
Anti-Arrhythmia Agents	0.132
Adrenergic beta-1 Receptor Antagonists	0.119
Vitamin B Complex	0.116
Anticoagulants	0.114
Rodenticides	0.107
Sodium Potassium Chloride Symporter Inhibitors	0.095
Diuretics	0.091
Angiotensin-Converting Enzyme Inhibitors	0.091
===== phenotype 20=================================================================
proportion of pts: 0.153907179691
lambda: 7805.07800102
----------------------------------------
Dorsopathies	0.171
Hypertensive disease	0.167
Diabetes	0.157
Range name na	0.151
Disorders of lipoid metabolism	0.149
Rheumatism, excluding the back	0.117
Disorders of thyroid gland	0.088
----------------------------------------
Antiparkinson Agents	0.126
Excitatory Amino Acid Antagonists	0.125
Antimanic Agents	0.122
Analgesics	0.120
Antidepressive Agents, Tricyclic	0.119
Muscle Relaxants, Central	0.115
Analgesics, Non-Narcotic	0.103
Anti-Anxiety Agents	0.085
Hypoglycemic Agents	0.084
===== phenotype 5=================================================================
proportion of pts: 0.140817136057
lambda: 7747.25116285
----------------------------------------
General symptoms	0.136
Hypertensive disease	0.134
Range name na	0.126
Dorsopathies	0.120
Arthropathies and related disorders	0.114
Symptoms involving digestive system	0.101
Diseases of esophagus, stomach, and duodenum	0.095
Other diseases of intestines and peritoneum	0.091
Disorders of lipoid metabolism	0.083
----------------------------------------
Analgesics, Opioid	0.141
Narcotics	0.136
Antipruritics	0.128
Hypnotics and Sedatives	0.114
GABA Modulators	0.111
Anti-Anxiety Agents	0.101
Muscle Relaxants, Central	0.096
Antipsychotic Agents	0.087
Serotonin Uptake Inhibitors	0.086
===== phenotype 24=================================================================
proportion of pts: 0.159857199524
lambda: 7625.85219373
----------------------------------------
Other forms of heart disease	0.162
Hypertensive disease	0.162
Range name na	0.151
Diabetes	0.138
Disorders of lipoid metabolism	0.137
Symptoms involving respiratory system and other chest symptoms	0.126
Ischemic heart disease	0.125
----------------------------------------
Calcium Channel Blockers	0.151
Adrenergic beta-Antagonists	0.125
Anti-Bacterial Agents	0.120
Hypoglycemic Agents	0.112
Anticoagulants	0.110
Surface-Active Agents	0.104
Anti-Infective Agents, Urinary	0.098
Protein Synthesis Inhibitors	0.092
Rodenticides	0.088
===== phenotype 28=================================================================
proportion of pts: 0.134073780246
lambda: 7420.66613003
----------------------------------------
Ischemic heart disease	0.157
Hypertensive disease	0.131
Disorders of lipoid metabolism	0.128
Symptoms involving respiratory system and other chest symptoms	0.115
Range name na	0.105
Other forms of heart disease	0.096
Rheumatism, excluding the back	0.096
Arthropathies and related disorders	0.088
General symptoms	0.085
----------------------------------------
Explosive Agents	0.190
Purinergic P2Y Receptor Antagonists	0.162
Vasodilator Agents	0.160
Anticholesteremic Agents	0.135
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.129
Platelet Aggregation Inhibitors	0.120
Fibrinolytic Agents	0.105
===== phenotype 32=================================================================
proportion of pts: 0.164220547402
lambda: 7350.31814454
----------------------------------------
Hypertensive disease	0.139
Symptoms involving respiratory system and other chest symptoms	0.135
Other forms of heart disease	0.125
Disorders of lipoid metabolism	0.125
Range name na	0.114
General symptoms	0.095
Symptoms involving skin and other integumentary tissue	0.093
Other diseases of respiratory system	0.090
Anemias	0.083
----------------------------------------
Diuretics	0.190
Sodium Potassium Chloride Symporter Inhibitors	0.173
Adrenergic alpha-1 Receptor Antagonists	0.143
Sodium Chloride Symporter Inhibitors	0.111
Antihypertensive Agents	0.100
Anti-Infective Agents, Local	0.097
Gout Suppressants	0.096
Cyclooxygenase Inhibitors	0.090
===== phenotype 1=================================================================
proportion of pts: 0.142800476002
lambda: 7189.57852443
----------------------------------------
Ischemic heart disease	0.149
Disorders of lipoid metabolism	0.149
Other forms of heart disease	0.145
Symptoms involving respiratory system and other chest symptoms	0.134
Hypertensive disease	0.128
Other diseases of respiratory system	0.122
Diseases of arteries, arterioles, and capillaries	0.086
Disorders of fluid, electrolyte, and acid-base balance	0.086
----------------------------------------
Sympatholytics	0.147
Anti-Allergic Agents	0.144
Anti-Inflammatory Agents	0.141
Adrenergic beta-1 Receptor Antagonists	0.133
Anticholesteremic Agents	0.115
Antioxidants	0.115
Glucocorticoids	0.108
Bronchodilator Agents	0.097
===== phenotype 43=================================================================
proportion of pts: 0.132883776279
lambda: 7135.24330492
----------------------------------------
Chronic obstructive pulmonary disease and allied conditions	0.194
Rheumatism, excluding the back	0.136
Arthropathies and related disorders	0.135
Hypertensive disease	0.135
Disorders of lipoid metabolism	0.113
Diseases of esophagus, stomach, and duodenum	0.108
Ischemic heart disease	0.093
Other symptoms involving abdomen and pelvis	0.086
----------------------------------------
Bronchodilator Agents	0.114
Tocolytic Agents	0.108
Adrenergic beta-2 Receptor Agonists	0.103
Antipyretics	0.103
Proton Pump Inhibitors	0.103
Anti-Ulcer Agents	0.102
Anti-Inflammatory Agents, Non-Steroidal	0.095
Antihypertensive Agents	0.095
Cyclooxygenase Inhibitors	0.091
Parasympatholytics	0.086
===== phenotype 49=================================================================
proportion of pts: 0.145577151924
lambda: 7040.18431204
----------------------------------------
Rheumatism, excluding the back	0.138
Hypertensive disease	0.132
Dorsopathies	0.119
Arthropathies and related disorders	0.117
Diabetes	0.114
Na	0.103
Disorders of the peripheral nervous system	0.094
Neurotic, personality, nonpsychotic disorders	0.093
Organic sleep disorders	0.088
----------------------------------------
Sympatholytics	0.146
Anti-Arrhythmia Agents	0.143
Serotonin Uptake Inhibitors	0.136
Adrenergic beta-1 Receptor Antagonists	0.127
Antihypertensive Agents	0.119
Analgesics	0.113
Anti-Anxiety Agents	0.109
Adrenergic Uptake Inhibitors	0.107
===== phenotype 0=================================================================
proportion of pts: 0.145973819913
lambda: 6937.01777504
----------------------------------------
Range name na	0.135
Other diseases of urinary system	0.134
Hypertensive disease	0.117
Symptoms involving urinary system	0.112
Arthropathies and related disorders	0.111
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.107
Symptoms involving respiratory system and other chest symptoms	0.100
Disorders of thyroid gland	0.094
Rheumatism, excluding the back	0.089
----------------------------------------
Anti-Bacterial Agents	0.134
Dermatologic Agents	0.118
Immunosuppressive Agents	0.116
Analgesics, Opioid	0.112
Enzyme Inhibitors	0.112
Narcotics	0.106
Bronchodilator Agents	0.106
Anti-Infective Agents, Urinary	0.099
Antirheumatic Agents	0.095
===== phenotype 30=================================================================
proportion of pts: 0.138833796113
lambda: 6902.19940746
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.162
Other inflammatory conditions of skin and subcutaneous tissue	0.140
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.131
Disorders of the eye and adnexa	0.127
Disorders of fluid, electrolyte, and acid-base balance	0.121
Range name na	0.109
Nutritional deficiencies	0.109
General symptoms	0.100
----------------------------------------
Antihypertensive Agents	0.113
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.105
Diuretics	0.104
Vasodilator Agents	0.101
Antipyretics	0.100
Anticholesteremic Agents	0.098
Anti-Inflammatory Agents, Non-Steroidal	0.098
Anti-Arrhythmia Agents	0.095
Cyclooxygenase Inhibitors	0.095
Fibrinolytic Agents	0.091
===== phenotype 21=================================================================
proportion of pts: 0.143990479968
lambda: 6871.70661396
----------------------------------------
Other diseases of intestines and peritoneum	0.164
Benign neoplasm of other parts of digestive system	0.154
Disorders of lipoid metabolism	0.141
Diabetes	0.127
Diseases of veins and lymphatics, and other diseases of circulatory system	0.120
Disorders of thyroid gland	0.117
Drug dependence	0.094
Symptoms involving cardiovascular system	0.082
----------------------------------------
Antihypertensive Agents	0.119
Anticholesteremic Agents	0.099
Vasodilator Agents	0.098
Antipyretics	0.089
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.088
Anti-Inflammatory Agents, Non-Steroidal	0.087
Anti-Arrhythmia Agents	0.086
Angiotensin-Converting Enzyme Inhibitors	0.085
Cyclooxygenase Inhibitors	0.084
Diuretics	0.084
Hypnotics and Sedatives	0.082
===== phenotype 31=================================================================
proportion of pts: 0.140420468068
lambda: 6786.76213753
----------------------------------------
Other diseases of respiratory system	0.131
Disorders of fluid, electrolyte, and acid-base balance	0.120
Anemias	0.116
General symptoms	0.113
Symptoms involving respiratory system and other chest symptoms	0.112
Symptoms involving skin and other integumentary tissue	0.111
Dorsopathies	0.107
Pneumonia and influenza	0.099
Disorders of the peripheral nervous system	0.091
----------------------------------------
Proton Pump Inhibitors	0.151
Anti-Ulcer Agents	0.150
Anti-Bacterial Agents	0.127
Antipyretics	0.124
Antihypertensive Agents	0.117
Calcium Channel Blockers	0.114
Vasodilator Agents	0.114
Anti-Arrhythmia Agents	0.104
===== phenotype 37=================================================================
proportion of pts: 0.130107100357
lambda: 6739.3079518
----------------------------------------
Ischemic heart disease	0.136
Symptoms involving respiratory system and other chest symptoms	0.129
Diabetes	0.125
Hypertensive disease	0.112
Nephritis, nephrotic syndrome, and nephrosis	0.109
Other forms of heart disease	0.107
Miscellaneous diagnostic and therapeutic procedures	0.099
Other symptoms involving abdomen and pelvis	0.094
Rheumatism, excluding the back	0.090
----------------------------------------
Proton Pump Inhibitors	0.144
Anti-Ulcer Agents	0.141
Diuretics	0.115
Analgesics, Opioid	0.109
Sodium Potassium Chloride Symporter Inhibitors	0.106
Narcotics	0.102
Anti-Bacterial Agents	0.101
Gastrointestinal Agents	0.093
Antipruritics	0.088
===== phenotype 4=================================================================
proportion of pts: 0.122967076557
lambda: 6295.2600257
----------------------------------------
Cerebrovascular disease	0.142
Disorders of the eye and adnexa	0.121
Other disorders of the central nervous system	0.115
Symptoms involving head and neck	0.114
Symptoms involving skin and other integumentary tissue	0.112
General symptoms	0.108
Disorders of the peripheral nervous system	0.106
Mycoses	0.100
Symptoms involving nervous and musculoskeletal systems	0.083
----------------------------------------
Calcium Channel Blockers	0.120
Antihypertensive Agents	0.117
Vasodilator Agents	0.113
Antipyretics	0.112
Anti-Inflammatory Agents, Non-Steroidal	0.112
Analgesics, Non-Narcotic	0.111
Cyclooxygenase Inhibitors	0.106
Diuretics	0.105
Platelet Aggregation Inhibitors	0.104
===== phenotype 35=================================================================
proportion of pts: 0.154700515668
lambda: 6184.35872917
----------------------------------------
Diseases of esophagus, stomach, and duodenum	0.170
Other diseases of skin and subcutaneous tissue	0.143
Hypertensive disease	0.131
Disorders of lipoid metabolism	0.106
Neoplasm of uncertain behavior of other sites & tissues	0.098
Overweight, obesity and other hyperalimentation	0.093
Other diseases of the upper respiratory tract	0.091
Diseases of the ear and mastoid process	0.085
Abnormal results of function studies	0.083
----------------------------------------
Anti-Inflammatory Agents, Non-Steroidal	0.157
Cyclooxygenase Inhibitors	0.154
Antipyretics	0.153
Platelet Aggregation Inhibitors	0.150
Fibrinolytic Agents	0.146
Antihypertensive Agents	0.132
Vitamins	0.109
===== phenotype 42=================================================================
proportion of pts: 0.128123760413
lambda: 5425.85165204
----------------------------------------
Hypertensive disease	0.147
Range name na	0.127
Other forms of heart disease	0.119
Organic sleep disorders	0.109
Disorders of the eye and adnexa	0.106
Ischemic heart disease	0.106
Symptoms involving skin and other integumentary tissue	0.097
Rheumatism, excluding the back	0.095
Other diseases of skin and subcutaneous tissue	0.094
----------------------------------------
Enzyme Inhibitors	0.173
Dermatologic Agents	0.154
Immunosuppressive Agents	0.144
Antirheumatic Agents	0.117
Antimetabolites	0.108
Bronchodilator Agents	0.107
Sodium Potassium Chloride Symporter Inhibitors	0.104
Antimetabolites, Antineoplastic	0.093
===== phenotype 39=================================================================
proportion of pts: 0.126933756446
lambda: 5092.61512416
----------------------------------------
Diseases of male genital organs	0.235
Other diseases of urinary system	0.141
Symptoms involving respiratory system and other chest symptoms	0.118
Diabetes	0.118
Diseases of the ear and mastoid process	0.116
Malignant neoplasm of skin	0.102
Nonspecific abnormal findings on radiological and other examination of body structure	0.086
Malignant neoplasm of male and female genital organs	0.085
----------------------------------------
Antihypertensive Agents	0.122
Anticholesteremic Agents	0.106
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.105
Anti-Inflammatory Agents, Non-Steroidal	0.103
Vasodilator Agents	0.101
Antipyretics	0.100
Cyclooxygenase Inhibitors	0.099
Platelet Aggregation Inhibitors	0.090
Anti-Arrhythmia Agents	0.089
Anti-Inflammatory Agents	0.085
===== phenotype 22=================================================================
proportion of pts: 0.132883776279
lambda: 4994.717948
----------------------------------------
Hypertensive disease	0.158
Range name na	0.148
Other diseases of urinary system	0.126
Disorders of lipoid metabolism	0.117
Rheumatism, excluding the back	0.100
Symptoms involving urinary system	0.096
Arthropathies and related disorders	0.090
Symptoms involving digestive system	0.083
Diseases of esophagus, stomach, and duodenum	0.082
----------------------------------------
Antiemetics	0.181
Topoisomerase II Inhibitors	0.138
Anticonvulsants	0.135
Anti-Anxiety Agents	0.122
Antidepressive Agents, Second-Generation	0.117
Estrogens	0.113
Antipsychotic Agents	0.103
Antineoplastic Agents	0.091
===== phenotype 7=================================================================
proportion of pts: 0.130107100357
lambda: 4692.45351953
----------------------------------------
Diabetes	0.191
Anemias	0.151
Nutritional deficiencies	0.130
Organic sleep disorders	0.120
Nephritis, nephrotic syndrome, and nephrosis	0.114
Disorders of lipoid metabolism	0.111
Symptoms involving digestive system	0.099
Other diseases of the blood	0.085
----------------------------------------
Vitamins	0.152
Bone Density Conservation Agents	0.151
Anti-Allergic Agents	0.147
Anti-Inflammatory Agents	0.145
Antihypertensive Agents	0.142
Hypoglycemic Agents	0.137
Antipyretics	0.125
===== phenotype 23=================================================================
proportion of pts: 0.123760412535
lambda: 4590.70591268
----------------------------------------
Hypertensive disease	0.170
Range name na	0.145
General symptoms	0.126
Symptoms involving respiratory system and other chest symptoms	0.125
Other forms of heart disease	0.123
Disorders of lipoid metabolism	0.115
Arthropathies and related disorders	0.104
Symptoms involving cardiovascular system	0.093
----------------------------------------
Serotonin Uptake Inhibitors	0.184
Antidepressive Agents, Second-Generation	0.155
GABA Modulators	0.142
Antidepressive Agents, Tricyclic	0.138
Anticonvulsants	0.136
Antidepressive Agents	0.126
Adjuvants, Anesthesia	0.118
===== phenotype 3=================================================================
proportion of pts: 0.130900436335
lambda: 4444.82796392
----------------------------------------
Hypertensive disease	0.172
Other forms of heart disease	0.142
Range name na	0.138
Symptoms involving respiratory system and other chest symptoms	0.133
Disorders of lipoid metabolism	0.117
Rheumatism, excluding the back	0.105
Arthropathies and related disorders	0.102
General symptoms	0.090
----------------------------------------
Bone Density Conservation Agents	0.215
Antacids	0.130
Antipyretics	0.127
Phosphodiesterase Inhibitors	0.113
Tranquilizing Agents	0.109
Calcium Channel Blockers	0.108
Purinergic P1 Receptor Antagonists	0.102
Antihypertensive Agents	0.096
===== phenotype 40=================================================================
proportion of pts: 0.106703689012
lambda: 3596.89233689
----------------------------------------
Symptoms involving digestive system	0.186
Other diseases of digestive system	0.146
Diseases of esophagus, stomach, and duodenum	0.140
Hernia of abdominal cavity	0.129
Range name na	0.116
Noninfectious enteritis and colitis	0.100
Diseases of oral cavity, salivary glands, and jaws	0.091
Operations on the digestive system	0.091
----------------------------------------
Antihypertensive Agents	0.152
Proton Pump Inhibitors	0.129
Antipyretics	0.128
Anti-Inflammatory Agents, Non-Steroidal	0.126
Anti-Ulcer Agents	0.124
Cyclooxygenase Inhibitors	0.119
Vasodilator Agents	0.119
Fibrinolytic Agents	0.104
